Your session is about to expire
← Back to Search
Transradial Cardiac Catheterization for Chronic Kidney Disease (RADIAL-CKD Trial)
RADIAL-CKD Trial Summary
This trial will compare the incidence of a kidney complication called contrast-induced nephropathy between two ways of accessing the heart during a catheterization procedure.
RADIAL-CKD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRADIAL-CKD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RADIAL-CKD Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had contrast used in a medical test in the last 3 weeks.I have had heart bypass surgery in the past.I have had a cardiogenic shock in the past.I am under 18 years old.I am willing to be assigned randomly to a specific medical procedure.I am scheduled for a planned heart procedure in Lubbock, TX between January 2016 and January 2018.Your right radial artery fails a test to check blood flow.I am between 18 and 88 years old.You have had a catheterization procedure in the past 5 years.You have a condition that makes it difficult to access your arteries.My kidney function is low, with an eGFR between 15-59 mL/min.You are unable to access the specified artery for the procedure.
- Group 1: Transradial Access
- Group 2: Transfemoral Access
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the cap on the number of volunteers involved in this experiment?
"Affirmative. The information on clinicaltrials.gov confirms that this medical trial, initially published on October 1st 2016, is currently recruiting participants. One hundred individuals need to be recruited from a single site."
Is there an opportunity for me to participate in this scientific inquiry?
"This research initiative is seeking a cohort of 100 individuals aged 18-88 diagnosed with acute kidney injury who are scheduled to undergo non-emergent cardiac catheterization at University Medical Center Hospital, Lubbock, TX between January 2016 and 2018. Additionally, those meeting the above requirements must be willing to accept randomisation into either TFA or TRA procedures."
Are new participants being accepted for this clinical experiment?
"According to clinicaltrials.gov, this experiment is seeking suitable candidates and has been since October 1st 2016. The last edit was made on 10/10/2022."
To what degree might Transradial Access be deemed hazardous to patients?
"Transradial Access has attained a score of 3 as it is at the fourth stage in its clinical trial process, which implies that this treatment has already obtained approval."
Is eligibility for this trial limited to participants younger than 80 years old?
"This medical study is only recruiting applicants aged 18 to 88. There are 133 separate trials for younger participants and 853 studies that focus on elderly patients over the age of 65."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger